Overview
Sanofi supplies prescription medicines, vaccines and consumer-health products in Poland, including diabetes, rare-disease and OTC brands. It works with hospitals, pharmacies and wholesalers.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-12-01. Active
33 1050 0086 1000 0090 3021 4804- 68 1050 0086 1000 0090 3021 4853
- 23 1050 0086 1000 0090 3021 4887
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 1.4MPLN 1,407,588 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Dec 5, 2023 | Dissolution without liquidation opened | |
| Sep 13, 2021 | Commercial Companies Code notice | |
| Mar 4, 2021 | Merger plan | |
| Jun 4, 2012 | Merger plan |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
1368 tenders recorded as contractor: 275 national ($16,973,004) and 1093 EU ($7,336,280,265), and 1 as contracting authority.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 14, 2026 | Zakup i sukcesywna dostawa produktów leczniczych stosowanych w programach lekowych i RDTL(5] | –– | Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji | |
| Oct 13, 2026 | Dostawy produktów leczniczych różnych | –– | Wojewódzki Szpital Specjalistyczny w Legnicy | |
| Oct 13, 2026 | Dostawy leków, preparatów do żywienia dojelitowego, surowców farmaceutycznych, kontrastów, płynów infuzyjnych oraz roztworów zabezpieczających cewnik. | –– | Specjalistyczny Szpital Im. E. Szczeklika w Tarnowie |
Public sector contracts
Sanofi is the contractor in 240 public sector contracts, worth PLN 124.37m in total. They were signed with 84 public buyers. The largest number (4) were signed with Ministerstwo Zdrowia.
| Public buyer | Value | |
|---|---|---|
| Samodzielny Publiczny Zespół Opieki Zdrowotnej w Leżajsku | PLN 14.58 | |
| Szpital Specjalistyczny Im. Jędrzeja Śniadeckiego w Nowym Sączu | PLN 852.00 | |
| Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie | PLN 45.14 | |
| Szpital Bielański Im.Ks. Jerzego Popiełuszki Samodzielny Publiczny Zakład Opieki Zdrowotnej | PLN 19.90 | |
| Uniwersytecki Szpital Kliniczny w Białymstoku | PLN 278.00 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
A member of the management board independently
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sanofi Société Anonyme | 348,454 | $13,705,669.08 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Bayersp. z o.o. | $624,313,880.67 | talent.bayer.com | ||
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| Komtur Polskasp. z o.o. | $424,362,396.43 | komtur.pl | ||
| Novartis Polandsp. z o.o. | $378,147,128.47 | novartis.com | ||
| USP Zdrowiesp. z o.o. | $377,149,656.94 | uspzdrowie.pl | ||
| MSD Polska Dystrybucjasp. z o.o. | $341,786,056.16 | msd.pl | ||
| Pfizer Trading Polskasp. z o.o. | $299,067,553.99 | pfizer.pl | ||
| Medi&Moresp. z o.o. | $275,638,188.29 | medi-more.pl | ||
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Servier Polska Servicessp. z o.o. | $157,143,144.15 | servier.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-04-02 | Address change (Bonifraterska 17, 00-203, Warszawa → Ul. Marcina Kasprzaka 6, 01-211, Warszawa) | |
| 2024-04-02 | Name change (Sanofi-Aventis → Sanofi) | |
| 2014-02-24 | Share capital change (10,738,737.50 PLN → 50,738,386.94 PLN) | |
| 2013-06-03 | Share capital change (9,302,294.85 PLN → 10,738,737.50 PLN) | |
| 2012-08-31 | Share capital change (8,252,304.25 PLN → 9,302,294.85 PLN) |
FAQ
Last updated: 2026-10-02